Pointcross Life Sciences

Pointcross Life Sciences

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

PointCross Life Sciences is a private, revenue-generating software and services company founded in 2016, focusing on the high-compliance niche of clinical and nonclinical data orchestration for regulatory submissions. Its flagship XBIOM™ platform automates data transformation, validation, and reporting, integrating AI via secure, firewall-deployed LLMs to enable natural language querying of study data. The company claims significant efficiency gains, including reducing SEND and study report generation to 2-3 weeks, and serves biopharma sponsors and CROs by addressing critical bottlenecks in the drug development pathway.

AI / Machine LearningDrug Delivery

Technology Platform

XBIOM™ Clinical Data Automation Platform (CDAP) - an integrated suite for clinical/nonclinical data ingestion, curation, transformation (to SEND/SDTM/ADaM), validation, warehousing, and AI-powered analytics. Features secure, firewall-deployed LLMs for Retrieval-Augmented Generation (RAG) enabling natural language querying of study data.

Funding History

1
SeedUndisclosed

Opportunities

The mandatory adoption of SEND and CDISC standards by regulatory agencies creates a sustained, compliance-driven market.
The industry's urgent need for AI tools that do not compromise data security positions PointCross's firewall-deployed LLM approach as a key differentiator.
Growing data volumes from complex trials and biomarker assays increase demand for automated orchestration platforms.

Risk Factors

Faces competition from large clinical tech suites and specialized startups.
Revenue is tied to biopharma R&D budgets, which can be cyclical.
The value proposition is dependent on specific regulatory standards, which could change.
Long enterprise sales cycles may slow growth.

Competitive Landscape

Competes with large clinical trial technology providers (e.g., Veeva Vault Clinical, Medidata), specialized SEND service vendors, and legacy clinical data management system providers. Differentiation is based on the integrated 'Single Track' automation for nonclinical studies, the secure AI/LLM capability, and a platform that spans both clinical and nonclinical data.